Molecular Cytogenetics Market Report

Molecular Cytogenetics Market Analysis Report By Application (Oncology, Personalized Medicine), By Product, By End Use, By Technology (FISH, Immunochemistry, Karyotyping), And Segment Forecasts, 2018 - 2025

  • Published Date: Feb 2018
  • Report ID: GVR-1-68038-023-1
  • Number of Pages: 236
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016

Table of Content

Chapter 1 Executive Summary
                  1.1 Market Snapshot
Chapter 2 Research Methodology
                  2.1 Information Procurement
                  2.2 Information or Data Analysis
                  2.3 Market Formulation & Validation
Chapter 3 Molecular Cytogenetics Market Variables, Trends & Scope
                  3.1 Market Segmentation & Scope
                      3.1.1 Market driver analysis
                          3.1.1.1 Growing implementation of pharmacogenomics in personalized disease management and drug development
                          3.1.1.2 Rising cancer cases
                          3.1.1.3 Gradual advancements in cytogenetic techniques
                              3.1.1.3.1 Transition from array based technology to NGS technology
                          3.1.1.4 Growth in gene-based prediction of genetic abnormalities
                          3.1.1.5 Increasing importance molecular cytogenetic in crop improvement
                          3.1.1.6 Aging population & its vulnerability to chronic diseases
                      3.1.2 Market restraint analysis
                          3.1.2.1 High cost of instruments has restricted the adoption of cytogenetic techniques in developing and emerging nations
                          3.1.2.2 Lack of skilled personnel
                          3.1.2.3 Ambiguous regulatory & reimbursement scenario
                  3.2 Molecular Cytogenetics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                  3.3 Industry Analysis – Porter’s
                  3.4 Automation in Cytogenetic Laboratory: Demand and Implementation
                      3.4.1 Demand
                          3.4.1.1 Demand for development of automated sequencing technology:
                      3.4.2 Implementation
                  3.5 Costs of cytogenetics services offered by prominent players operating in this space
                  3.6 Cost comparison based on technique used in cytogenetic analysis
                  3.7 Service demand and the nature of services provided
                  3.8 Major service based contracts in the market
                  3.9 Opportunities with respect to service offerings in cytogenetics
                  3.10 Services for diagnostics
                  3.11 Services for research
Chapter 4 Molecular Cytogenetics: Application Estimates & Trend Analysis
                  4.1 Molecular Cytogenetics Market: Application Movement Analysis
                  4.2 Penetration & Growth Prospect Mapping for Application, 2016
                  4.3 Genetic Disorders
                      4.3.1 Global genetic disorders market, 2014 - 2025 (USD Million)
                  4.4 Oncology
                      4.4.1 Global oncology market, 2014 - 2025 (USD Million)
                  4.5 Personalized Medicine
                      4.5.1 Global personalized medicine market, 2014 - 2025 (USD Million)
                  4.6 Other Applications
                      4.6.1 Global other applications market, 2014 - 2025 (USD Million)
Chapter 5 Molecular Cytogenetics: Product Estimates & Trend Analysis
                  5.1 Global Molecular Cytogenetics Market: Product Movement Analysis
                  5.2 Penetration & Growth Prospect Mapping for Product, 2016
                  5.3 Instruments
                      5.3.1 Global instruments market, 2014 - 2025 (USD Million)
                  5.4 Consumables
                      5.4.1 Global consumables market, 2014 - 2025 (USD Million)
                  5.5 Software & Services
                      5.5.1 Global software & services market, 2014 - 2025 (USD Million)
Chapter 6 Molecular Cytogenetics: End-use Estimates & Trend Analysis
                  6.1 Molecular Cytogenetics Market: End-use Movement Analysis
                  6.2 Penetration & Growth Prospect Mapping for End-use, 2016
                  6.3 Clinical & Research Laboratories
                  6.4 Clinical Cytogenetics
                      6.4.1 New cancer cases, U.S.
                      6.4.2 Global clinical & research laboratories market, 2014 - 2025 (USD Million)
                  6.5 Hospitals & Pathology Laboratories
                      6.5.1 Global hospitals & pathology laboratories market, 2014 - 2025 (USD Million)
                  6.6 Academic Research Institutes
                      6.6.1 Global academic research institutes market, 2014 - 2025 (USD Million)
                  6.7 Pharmaceutical and Biotechnology Companies
                      6.7.1 Global pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
                  6.8 Other End Users
                      6.8.1 Global other end users market, 2014 - 2025 (USD Million)
Chapter 7 Molecular Cytogenetics: Technology Estimates & Trend Analysis
                  7.1 Global Molecular Cytogenetics Market: Technology Movement Analysis
                      7.1.1 Comparative analysis of technologies
                          7.1.1.1 Comparative analysis of various molecular cytogenetic techniques
                          7.1.1.2 Comparative analysis of conventional and molecular cytogenetic techniques
                  7.2 Penetration & Growth Prospect Mapping for Technology, 2016
                  7.3 Comparative Genomic Hybridization
                      7.3.1 Global comparative genomic hybridization market, 2014 - 2025 (USD Million)
                      7.3.2 Array-based comparative genomic hybridization
                          7.3.2.1 Global array-based comparative genomic hybridization market, 2014 - 2025 (USD Million)
                      7.3.3 Standard comparative genomic hybridization
                          7.3.3.1 Global standard comparative genomic hybridization market, 2014 - 2025 (USD Million)
                  7.4 Fluorescence In Situ Hybridization (FISH)
                      7.4.1 Global fluorescence in situ hybridization market, 2014 - 2025 (USD Million)
                  7.5 Immunohistochemistry
                      7.5.1 Global immunohistochemistry market, 2014 - 2025 (USD Million)
                  7.6 Karyotyping
                      7.6.1 Global karyotyping market, 2014 - 2025 (USD Million)
                      7.6.2 Spectral karyotyping
                          7.6.2.1 Global spectral karyotyping market, 2014 - 2025 (USD Million)
                      7.6.3 Virtual karyotyping
                          7.6.3.1 Global virtual karyotyping market, 2014 - 2025 (USD Million)
                  7.7 Other Techniques
                      7.7.1 Global other techniques market, 2014 - 2025 (USD Million)
Chapter 8 Molecular Cytogenetics: Regional Estimates & Trend Analysis, by Application, Product, End-use, & Technology
                  8.1 Molecular Cytogenetics Market Share By Region, 2015 & 2025
                  8.2 North America
                      8.2.1 North America molecular cytogenetics market, 2014 - 2025 (USD Million)
                      8.2.2 U.S.
                          8.2.2.1 U.S. molecular cytogenetics culture market, by application, 2014 - 2025 (USD Million)
                          8.2.2.2 U.S. molecular cytogenetics culture market, by product, 2014 - 2025 (USD Million)
                          8.2.2.3 U.S. molecular cytogenetics culture market, by end-use, 2014 - 2025 (USD Million)
                          8.2.2.4 U.S. molecular cytogenetics culture market, by technology, 2014 - 2025 (USD Million)
                      8.2.3 Canada
                          8.2.3.1 Canada molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.2.3.2 Canada molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.2.3.3 Canada molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.2.3.4 Canada molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
                  8.3 Europe
                      8.3.1 Europe molecular cytogenetics market, 2014 - 2025 (USD Million)
                      8.3.2 Germany
                          8.3.2.1 Germany molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.3.2.2 Germany molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.3.2.3 Germany molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.3.2.4 Germany molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
                      8.3.3 U.K.
                          8.3.3.1 U.K. molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.3.3.2 U.K. molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.3.3.3 U.K. molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.3.3.4 U.K. molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
                  8.4 Asia Pacific
                      8.4.1 Asia Pacific molecular cytogenetics market, 2014 - 2025 (USD Million)
                      8.4.2 Japan
                          8.4.2.1 Japan molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.4.2.2 Japan molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.4.2.3 Japan molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.4.2.4 Japan molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
                      8.4.3 China
                          8.4.3.1 China molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.4.3.2 China molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.4.3.3 China molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.4.3.4 China molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
                  8.5 Latin America
                      8.5.1 Latin America molecular cytogenetics market, 2014 - 2025 (USD Million)
                      8.5.2 Brazil
                          8.5.2.1 Brazil molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.5.2.2 Brazil molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.5.2.3 Brazil molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.5.2.4 Brazil molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
                  8.6 Middle East & Africa
                      8.6.1 Middle East & Africa molecular cytogenetics market, 2014 - 2025 (USD Million)
                      8.6.2 South Africa
                          8.6.2.1 South Africa molecular cytogenetics market, by application, 2014 - 2025 (USD Million)
                          8.6.2.2 South Africa molecular cytogenetics market, by product, 2014 - 2025 (USD Million)
                          8.6.2.3 South Africa molecular cytogenetics market, by end-use, 2014 - 2025 (USD Million)
                          8.6.2.4 South Africa molecular cytogenetics market, by technology,2014 - 2025 (USD Million)
Chapter 9 Competitive Landscape
                  9.1 Strategy Framework
                  9.2 Market Participation Categorization
                  9.3 Company market share analysis
                      9.3.1 Company size
                      9.3.2 Product portfolio
                      9.3.3 Geographical presence
                      9.3.4 Mergers and collaborations
                      9.3.5 Distribution networks
                      9.3.6 Segment coverage
                      9.3.7 Conclusion
                  9.4 Company Profiles
                      9.4.1 BIOVIEW
                          9.4.1.1 Company overview
                          9.4.1.2 Financial performance
                          9.4.1.3 Product benchmarking
                          9.4.1.4 Strategic initiatives
                      9.4.2 Danaher
                          9.4.2.1 Company overview
                              9.4.2.1.1 Leica Biosystems Nussloch GmbH
                          9.4.2.2 Financial performance
                              9.4.2.2.1 Financial performance
                          9.4.2.3 Product benchmarking
                          9.4.2.4 Strategic initiatives
                      9.4.3 MetaSystems
                          9.4.3.1 Company overview
                          9.4.3.2 Financial performance
                          9.4.3.3 Product benchmarking
                          9.4.3.4 Strategic initiatives
                      9.4.4 Agilent Technologies, Inc.
                          9.4.4.1 Company overview
                          9.4.4.2 Financial performance
                          9.4.4.3 Product benchmarking
                          9.4.4.4 Strategic initiatives
                      9.4.5 Abbott
                          9.4.5.1 Company overview
                          9.4.5.2 Financial performance
                          9.4.5.3 Product benchmarking
                          9.4.5.4 Strategic initiatives
                      9.4.6 Bio-Rad Laboratories, Inc.
                          9.4.6.1 Company overview
                          9.4.6.2 Financial performance
                          9.4.6.3 Product benchmarking
                          9.4.6.4 Strategic initiatives
                      9.4.7 Illumina, Inc.
                          9.4.7.1 Company overview
                          9.4.7.2 Financial performance
                          9.4.7.3 Product benchmarking
                          9.4.7.4 Strategic initiatives
                      9.4.8 Oxford Gene Technology
                          9.4.8.1 Company overview
                          9.4.8.2 Financial performance
                          9.4.8.3 Product benchmarking
                          9.4.8.4 Strategic initiatives
                      9.4.9 F. Hoffmann-La Roche Ltd
                          9.4.9.1 Company overview
                              9.4.9.1.1 Genentech, Inc.
                          9.4.9.2 Financial performance
                          9.4.9.3 Financial performance
                          9.4.9.4 Product benchmarking
                          9.4.9.5 Strategic initiatives
                      9.4.10 PerkinElmer Inc.
                          9.4.10.1 Company overview
                          9.4.10.2 Financial performance
                          9.4.10.3 Product benchmarking
                          9.4.10.4 Strategic initiatives
                      9.4.11 Quest Diagnostics Incorporated
                          9.4.11.1 Company overview
                              9.4.11.1.1 Sonora Quest Laboratories
                          9.4.11.2 Financial performance
                              9.4.11.2.1 Financial performance
                          9.4.11.3 Product benchmarking
                          9.4.11.4 Product benchmarking
                          9.4.11.5 Strategic initiatives
                      9.4.12 Applied Spectral Imaging
                          9.4.12.1 Company overview
                          9.4.12.2 Financial performance
                          9.4.12.3 Product benchmarking
                          9.4.12.4 Strategic initiatives
                      9.4.13 Biological Industries USA, Inc.
                          9.4.13.1 Company overview
                          9.4.13.2 Financial performance
                          9.4.13.3 Product benchmarking
                          9.4.13.4 Strategic initiatives
                      9.4.14 CytoTest
                          9.4.14.1 Company overview
                          9.4.14.2 Financial performance
                          9.4.14.3 Product benchmarking
                          9.4.14.4 Strategic initiatives
                      9.4.15 Cytognomix
                          9.4.15.1 Company overview
                          9.4.15.2 Financial performance
                          9.4.15.3 Product benchmarking
                      9.4.16 Genial Genetics
                          9.4.16.1 Company overview
                          9.4.16.2 Financial performance
                          9.4.16.3 Product benchmarking
                          9.4.16.4 Strategic initiatives
                      9.4.17 Diagnostic Cytogenetics, Inc. (DCI)
                          9.4.17.1 Company overview
                          9.4.17.2 Financial performance
                          9.4.17.3 Product benchmarking
                      9.4.18 Hospital/standalone laboratory/University/Academic institute based cytogenetic services
                          9.4.18.1 Weill Cornell Medicine
                              9.4.18.1.1 Company overview
                              9.4.18.1.2 Financial performance
                              9.4.18.1.3 Service benchmarking
                          9.4.18.2 UCLA Health - UCLA Pathology and Laboratory Medicines
                              9.4.18.2.1 Company overview
                              9.4.18.2.2 Financial performance
                              9.4.18.2.3 Service benchmarking
                          9.4.18.3 OHSU School of Medicine-Molecular and Medical Genetics
                              9.4.18.3.1 Company overview
                              9.4.18.3.2 Financial performance
                              9.4.18.3.3 Service benchmarking
                          9.4.18.4 Integrated Systems Engineering S.r.l.
                              9.4.18.4.1 Company overview
                              9.4.18.4.2 Financial performance
                              9.4.18.4.3 Product benchmarking
                          9.4.18.5 WiCell Research Institute, Inc.
                              9.4.18.5.1 Company overview
                              9.4.18.5.2 Financial performance
                              9.4.18.5.3 Product benchmarking
                          9.4.18.6 Virtual Scientific
                              9.4.18.6.1 Company overview
                              9.4.18.6.2 Financial performance
                              9.4.18.6.3 Product benchmarking
                          9.4.18.7 UW Cytogenetic Services
                              9.4.18.7.1 Company overview
                              9.4.18.7.2 Financial performance
                              9.4.18.7.3 Service benchmarking
                          9.4.18.8 Genesis Laboratories Inc.
                              9.4.18.8.1 Company overview
                              9.4.18.8.2 Financial performance
                              9.4.18.8.3 Product benchmarking
                          9.4.18.9 Calgary Laboratory Services
                              9.4.18.9.1 Company overview
                              9.4.18.9.2 Financial performance
                              9.4.18.9.3 Product benchmarking
                          9.4.18.10 Neogenomics
                              9.4.18.10.1 Company overview
                              9.4.18.10.2 Financial performance
                              9.4.18.10.3 Product benchmarking
                          9.4.18.11 ARUP Laboratories
                              9.4.18.11.1 Company overview
                              9.4.18.11.2 Financial performance
                              9.4.18.11.3 Product benchmarking
                              9.4.18.11.4 Strategic initiatives
                          9.4.18.12 South West Thames Regional Genetics Service
                              9.4.18.12.1 Company overview
                              9.4.18.12.2 Financial performance
                              9.4.18.12.3 Service benchmarking


List of Tables

TABLE 1 Prices for chromosome and/or FISH analysis
TABLE 2 Prices for cytogenetics services at University of Colorado Cancer Center
TABLE 3 Cytogenetics Unit Service List
TABLE 4 Cost comparison for chromosome testing of miscarriage specimens
TABLE 5 Average costs for cytogenetics testing for Idiopathic Learning Disability in the U.K.
TABLE 6 Average costs for karyotype testing in the U.S.
TABLE 7 Comparison of the types of chromosomal abnormalities that can be detected by karyotype and array CGH
TABLE 8 Current method of choice for required tests associated with specific tumor types
TABLE 9 Demographics of patients undergoing (Dilation and Curettage) D&C for first-trimester miscarriage
TABLE 10 FISH test panels for hematology/oncology available with Singapore General Hospital
TABLE 11 Algorithm following positive NIPS results for prenatal diagnostics
TABLE 12 Average number of cytogenetics tests performed by hospitals/laboratories annually
TABLE 13 Clinical indications and techniques employed by cytogenetics laboratories
TABLE 14 Highly assessed/cited papers published in molecular cytogenetics
TABLE 15 Example of some genomic disorders that can be detected by chromosomal microarray analysis
TABLE 16 North America molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 17 North America molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 18 North America molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 19 North America molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 20 North America comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 21 North America karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 22 U.S. molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 23 U.S. molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 24 U.S. molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 25 U.S. molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 26 U.S. comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 27 U.S. karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 28 Canada molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 29 Canada molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 30 Canada molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 31 Canada molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 32 Canada comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 33 Canada karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 34 Europe molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 35 Europe molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 36 Europe molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 37 Europe molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 38 Europe comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 39 Europe karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 40 Germany molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 41 Germany molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 42 Germany molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 43 Germany molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 44 Germany comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 45 Germany karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 46 U.K. molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 47 U.K. molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 48 U.K. molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 49 U.K. molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 50 U.K. comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 51 U.K. karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 52 Asia Pacific molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 53 Asia Pacific molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 54 Asia Pacific molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 55 Asia Pacific molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 56 Asia Pacific comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 57 Asia Pacific karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 58 Japan molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 59 Japan molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 60 Japan molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 61 Japan molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 62 Japan comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 63 Japan karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 64 China molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 65 China molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 66 China molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 67 China molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 68 China comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 69 China karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 70 Latin America molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 71 Latin America molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 72 Latin America molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 73 Latin America molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 74 Latin America comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 75 Latin America karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 76 Brazil molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 77 Brazil molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 78 Brazil molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 79 Brazil molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 80 Brazil comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 81 Brazil karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 82 MEA molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 83 MEA molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 84 MEA molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 85 MEA molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 86 MEA comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 87 MEA karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 88 South Africa molecular cytogenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 89 South Africa molecular cytogenetics market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 90 South Africa molecular cytogenetics market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 91 South Africa molecular cytogenetics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 92 South Africa comparative genomic hybridization market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 93 South Africa karyotyping market estimates & forecasts, by technology, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market summary
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 FDA-approved pharmacogenomics biomarker in drug labeling as of 2016
FIG. 1 Estimated new cancers, female, 2016
FIG. 2 Estimated new cancers, male, 2016
FIG. 3 Distribution of persons aged 60 years or above, by region, 2017 & 2050
FIG. 4 Market restraint relevance analysis (Current & future impact)
FIG. 5 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 6 Porter’s Five Forces Analysis
FIG. 7 Molecular cytogenetics market: Application outlook key takeaways
FIG. 8 Global Molecular cytogenetics market: Application movement analysis
FIG. 9 Penetration & growth prospect mapping for Application, 2016
FIG. 10 Global genetic disorders market, 2014 - 2025 (USD Million)
FIG. 11 Global oncology market, 2014 - 2025 (USD Million)
FIG. 12 Global personalized medicine market, 2014 - 2025 (USD Million)
FIG. 13 Global other applications market, 2014 - 2025 (USD Million)
FIG. 14 Molecular cytogenetics market: Product outlook key takeaways
FIG. 15 Global molecular cytogenetics market: Product movement analysis
FIG. 16 Penetration & growth prospect mapping for Product, 2016
FIG. 17 Global instruments market, 2014 - 2025 (USD Million)
FIG. 18 Global consumables market, 2014 - 2025 (USD Million)
FIG. 19 Global software & services market, 2014 - 2025 (USD Million)
FIG. 20 Molecular cytogenetics market: End-use outlook key takeaways
FIG. 21 Global molecular cytogenetics market: End-use movement analysis
FIG. 22 Penetration & growth prospect mapping for end-use, 2016
FIG. 23 New cancer cases, U.S.
FIG. 24 Global clinical & research laboratories market, 2014 - 2025 (USD Million)
FIG. 25 Global hospitals & pathology laboratories market, 2014 - 2025 (USD Million)
FIG. 26 Global academic research institutes market, 2014 - 2025 (USD Million)
FIG. 27 Global pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
FIG. 28 Global other end users market, 2014 - 2025 (USD Million)
FIG. 29 Molecular cytogenetics market: Technology outlook key takeaways
FIG. 30 Advantages & limitations: Molecular cytogenetic analysis
FIG. 31 Comparison of cytogenetic techniques for identifying chromosomal abnormalities
FIG. 32 Advantages & limitations: Molecular cytogenetic analysis
FIG. 33 Advantages & limitations: Conventional cytogenetic analysis
FIG. 34 Global molecular cytogenetics market: Technology movement analysis
FIG. 35 Penetration & growth prospect mapping for Technology, 2016
FIG. 36 Global comparative genomic hybridization market, 2014 - 2025 (USD Million)
FIG. 37 Global array-based comparative genomic hybridization market, 2014 - 2025 (USD Million)
FIG. 38 Global standard comparative genomic hybridization market, 2014 - 2025 (USD Million)
FIG. 39 Global fluorescence in situ hybridization market, 2014 - 2025 (USD Million)
FIG. 40 Global immunohistochemistry market, 2014 - 2025 (USD Million)
FIG. 41 Global karyotyping market, 2014 - 2025 (USD Million)
FIG. 42 Global spectral karyotyping market, 2014 - 2025 (USD Million)
FIG. 43 Global virtual karyotyping market, 2014 - 2025 (USD Million)
FIG. 44 Global other techniques market, 2014 - 2025 (USD Million)
FIG. 45 Regional market place: Key takeaway
FIG. 46 Molecular cytogenetics regional outlook, 2015 & 2025
FIG. 47 North America molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 48 U.S molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 49 Canada molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 50 Europe molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 51 Germany molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 52 U.K. molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 53 Asia Pacific molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 54 Japan molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 55 China molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 56 Latin America molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 57 Brazil molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 58 Middle East & Africa molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 59 South Africa molecular cytogenetics market, 2014 - 2025 (USD Million)
FIG. 60 Strategy framework
FIG. 61 Participant categorization
FIG. 62 Company market share analysis, product manufacturers 2016
FIG. 63 Company market share analysis, Service providers 2016

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.